We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Product News

Cellceutix Makes Breakthrough in Cancer Research by Activating p53, the "Guardian Angel of the Human Genome"

p53 is a tumor suppressor protein that is encoded by the TP53 gene in humans and has been widely regarded as possibly holding a key to the future of cancer therapies.
Product News

Helix BioPharma Reports Issuance of U.S. Patent for the Lung Cancer-Specific Antibody Used in Its Drug Candidate L-DOS47

L-DOS47 combines Helix's DOS47 technology with NRC's highly specialized camelid-derived single domain antibody to identify a unique CEACAM6 antigenic site associated with NSCLC cells.
Product News

DiaMedica Announces Positive Results from a Hypertension Study With its GSK3B-Blocking Antibody

DiaMedica announces antihypertensive results with antibody DM-204.
Product News

Helix BioPharma Files European Clinical Trial Application for a Phase I/II Study of its Lung Cancer Drug Candidate L-DOS47

L-DOS47 is intended to offer an innovative approach to the first-line treatment of inoperable, locally advanced, recurrent or metastatic, non-small cell lung cancer.
Product News

Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.
Product News

OGT Presents Prostate Cancer Data at the CHI Early Oncology Partnering Showcase and Tri-Con 2011

Oxford Gene Technology (OGT)is discussing recent developments in biomarker discovery at this year’s CHI International Molecular Medicine Tri-Conference (Tri-Con) in San Francisco, USA (23-25th February).
Product News

Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia

Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.
Product News

Lorus Therapeutics Announces Publication on LOR-2040 Anticancer Activity in Acute Myeloid Leukemia

Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.
Product News

Taconic to Offer DuPont™ OncoMouse® Oncology Models for Use in Cancer Research

Company expands translational oncology research services by performing efficacy and compound profiling studies and making novel spontaneous tumor mouse models.
Product News

Sigma® Life Science Launches Oncology Disease Model Cell Lines

New tools for understanding biological pathways and accelerating drug development for personalized medicine.
Advertisement